Zymeworks Competitors and Similar CompaniesClear all
NovoCure's competitors and similar companies include Gossamer Bio and Foghorn Therapeutics.
 NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. |  Gossamer Bio Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2000 | Founding Date 2015 | Founding Date 2016 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Diego, US HQ Dublin 2, IE | Locations Cambridge, US HQ Cambridge, US | |
Employees | Employees 1,488 | Employees 11820% increase | Employees 1123% decrease |
Valuation ($) | Valuation ($) 1.8 b | Valuation ($) 208 m | Valuation ($) 452 m |
Financial | |||
Revenue (est.) | Revenue (est.) $655.4m (FY, 2025) | Revenue (est.) $48.5m (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($136.2m) (FY, 2025) | Net income ($170.4m) (FY, 2025) | Net income ($74.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 480m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Gossamer Bio
HQ
San Diego, US
Employees
118↑ 20% increase
Gossamer Bio is a company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations.
View companyFoghorn Therapeutics
HQ
Cambridge, US
Employees
112↓ 3% decrease
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company